Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James H Lewis

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Digestive Diseases (Basel, Switzerland)|October 8, 2010
Hepatotoxicity of agents used in the management of inflammatory bowel diseaseOmar S Khokhar, James H Lewis
Drug Safety|January 21, 2014
Sumatriptan-associated ischemic colitis: case report and review of the literature and FAERSThuc Quyen Nguyen, James H Lewis
Clinics in Liver Disease|August 29, 2007
Causality assessment of drug-induced hepatotoxicity: promises and pitfallsMax A Shapiro, James H Lewis
Clinics in Liver Disease|April 2, 2018
Nonacetaminophen Drug-Induced Acute Liver FailureArul M Thomas, James H Lewis
Digestive Diseases and Sciences|March 16, 2007
Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time?Omar S Khokhar, James H Lewis
Clinics in Liver Disease|October 9, 2013
Hepatotoxicity of antibiotics: a review and update for the clinicianJonathan G Stine, James H Lewis
Expert Review of Gastroenterology & Hepatology|December 4, 2015
Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic reviewJonathan G Stine, James H Lewis
Clinical Liver Disease|March 7, 2020
The Origins of the Modern-Day Study of Drug Hepatotoxicity: Focus on Hyman J. ZimmermanJames H Lewis, Leonard B Seeff
Expert Opinion on Drug Metabolism & Toxicology|April 23, 2011
Drug-induced liver injury: a summary of recent advancesJonathan G Stine, James H Lewis
The Annals of Pharmacotherapy|April 12, 2007
Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infectionAngelo H Paredes, James H Lewis
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Digestive Diseases (Basel, Switzerland)|October 8, 2010
Hepatotoxicity of agents used in the management of inflammatory bowel diseaseOmar S Khokhar, James H Lewis
Drug Safety|January 21, 2014
Sumatriptan-associated ischemic colitis: case report and review of the literature and FAERSThuc Quyen Nguyen, James H Lewis
Clinics in Liver Disease|August 29, 2007
Causality assessment of drug-induced hepatotoxicity: promises and pitfallsMax A Shapiro, James H Lewis
Clinics in Liver Disease|April 2, 2018
Nonacetaminophen Drug-Induced Acute Liver FailureArul M Thomas, James H Lewis
Digestive Diseases and Sciences|March 16, 2007
Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time?Omar S Khokhar, James H Lewis
Clinics in Liver Disease|October 9, 2013
Hepatotoxicity of antibiotics: a review and update for the clinicianJonathan G Stine, James H Lewis
Expert Review of Gastroenterology & Hepatology|December 4, 2015
Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic reviewJonathan G Stine, James H Lewis
Clinical Liver Disease|March 7, 2020
The Origins of the Modern-Day Study of Drug Hepatotoxicity: Focus on Hyman J. ZimmermanJames H Lewis, Leonard B Seeff
Expert Opinion on Drug Metabolism & Toxicology|April 23, 2011
Drug-induced liver injury: a summary of recent advancesJonathan G Stine, James H Lewis
The Annals of Pharmacotherapy|April 12, 2007
Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infectionAngelo H Paredes, James H Lewis
Pageof 10